Capricor Therapeutics Stock (NASDAQ: CAPR) stock price, news, charts, stock research, profile.
Open | $6.230 |
Close | $6.300 |
Volume / Avg. | 404.419K / 355.449K |
Day Range | 6.146 - 6.410 |
52 Wk Range | 2.680 - 8.221 |
Market Cap | $200.412M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 65 |
Short Interest | 15.66% |
Days to Cover | 8.36 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Capricor Therapeutics (NASDAQ: CAPR) through any online brokerage.
Other companies in Capricor Therapeutics’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Galectin Therapeutics (NASDAQ:GALT), Adverum Biotechnologies (NASDAQ:ADVM), bluebird bio (NASDAQ:BLUE) and Atossa Therapeutics (NASDAQ:ATOS).
The latest price target for Capricor Therapeutics (NASDAQ: CAPR) was reported by Oppenheimer on Friday, May 17, 2024. The analyst firm set a price target for 14.00 expecting CAPR to rise to within 12 months (a possible 122.22% upside). 9 analyst firms have reported ratings in the last year.
The stock price for Capricor Therapeutics (NASDAQ: CAPR) is $6.3 last updated May 20, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Capricor Therapeutics.
Capricor Therapeutics’s Q2 earnings are confirmed for Monday, August 5, 2024.
There is no upcoming split for Capricor Therapeutics.
Capricor Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.